Tenax Therapeutics Inc.

NASDAQ: TENX · Real-Time Price · USD
5.85
-0.10 (-1.68%)
At close: Aug 15, 2025, 12:51 PM

Tenax Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.6M -7.71M -11.05M -32.47M
Depreciation & Amortization
n/a 7.57K 113.33K 108.98K
Stock-Based Compensation
1.13M n/a 365.31 773.79
Other Working Capital
523K 237K -119.39K -587.59K
Other Non-Cash Items
23K 215.94K 366.86K 22.12M
Deferred Income Tax
n/a n/a -365 -773
Change in Working Capital
1.64M 1.58M -1.45M -610.09K
Operating Cash Flow
-14.81M -5.9M -12.01M -10.86M
Capital Expenditures
n/a 2.84K -2.32K -5.25K
Cash Acquisitions
n/a n/a n/a -457
Purchase of Investments
n/a n/a n/a -345.54K
Sales Maturities Of Investments
n/a n/a n/a 803.4K
Other Investing Acitivies
n/a n/a n/a 457.86
Investing Cash Flow
n/a 2.84K -2.32K 452.61K
Debt Repayment
-501K -624.3K 624.3K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 544.65K
Financial Cash Flow
99.87M 13.57M 8.55M 9.74M
Net Cash Flow
85.06M 7.67M -3.46M -666.32K
Free Cash Flow
-14.81M -5.9M -12.02M -10.86M